Generic Name and Formulations:
Caprylic triglyceride, potassium caseinate (milk-derived protein), maltodextrin, whey protein (milk-derived), sugar, sunflower oil, dimagnesium phosphate, tricalcium phosphate, dipotassium phosphate, soy lecithin, distilled monoglyceride, silicon dioxide, natural vanilla bean extract, sucralose, acesulfame potassium; pwd; 40g per packet.
Indications for AXONA:
Dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
1 packet once daily after meals; add contents of packet in 4–8oz of water or preferred liquids, mix thoroughly. May start with a graduated dosing regimen for 7 days before taking one full packet per day.
Milk or soy allergy.
Risk of ketoacidosis (eg, alcoholics, poorly controlled diabetics). History of GI inflammatory conditions (eg, IBS, diverticular disease, chronic gastritis, severe GERD). Renal dysfunction. Monitor triglyceride levels during therapy.
GI upset, flatulence, dyspepsia, dizziness, headache, increases in BUN, uric acid, or creatinine.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Risk of Developing Multiple Sclerosis After HPV Vaccination
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid-Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics